Works matching DE "AMERICAN Society for Clinical Pharmacology %26 Therapeutics"
1
- CPT: Pharmacometrics & Systems Pharmacology, 2019, v. 8, n. 1, p. 1, doi. 10.1002/psp4.12326
- Article
2
- CPT: Pharmacometrics & Systems Pharmacology, 2016, v. 5, n. 12, p. 647, doi. 10.1002/psp4.12030
- Article
3
- CPT: Pharmacometrics & Systems Pharmacology, 2016, v. 5, n. 9, p. 447, doi. 10.1002/psp4.12027
- Article
4
- CPT: Pharmacometrics & Systems Pharmacology, 2015, v. 4, n. 10, p. i, doi. 10.1002/psp4.12046
- Article
5
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 6, p. 1281, doi. 10.1002/cpt.1445
- Article
7
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 284, doi. 10.1002/cpt.1326
- Article
8
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 6, p. 1049, doi. 10.1002/cpt.1247
- Article
9
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 4, p. 597, doi. 10.1002/cpt.1206
- Article
10
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 418, doi. 10.1002/cpt.1173
- Article
11
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 401, doi. 10.1002/cpt.844
- Article
12
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 2, p. 227, doi. 10.1002/cpt.1141
- Article
13
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 1, p. 14, doi. 10.1002/cpt.1106
- Article
14
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 6, p. 938, doi. 10.1002/cpt.1091
- Article
15
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 5, p. 738, doi. 10.1002/cpt.1068
- Article
16
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 4, p. 547, doi. 10.1002/cpt.1043
- Article
18
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 3, p. 367, doi. 10.1002/cpt.1025
- Article
19
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 2, p. 162, doi. 10.1002/cpt.977
- Article
20
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 1, p. 15, doi. 10.1002/cpt.935
- Article
21
- Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 885, doi. 10.1002/cpt.880
- Article
22
- Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 5, p. 733, doi. 10.1002/cpt.816
- Article
23
- Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 4, p. 570, doi. 10.1002/cpt.796
- Article
24
- Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 3, p. 380, doi. 10.1002/cpt.766
- Article
25
- Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 2, p. 171, doi. 10.1002/cpt.741
- Article
26
- Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 1, p. 15, doi. 10.1002/cpt.713
- Article
27
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 6, p. 709, doi. 10.1002/cpt.678
- Article
28
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 4, p. 437, doi. 10.1002/cpt.624
- Article
29
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 3, p. 310, doi. 10.1002/cpt.607
- Article
30
- Clinical Pharmacology & Therapeutics, 2017, v. 101, p. n/a, doi. 10.1002/cpt.571
- Article
31
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 160, doi. 10.1002/cpt.580
- Article
32
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 1, p. 15, doi. 10.1002/cpt.556
- Article
33
- Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 6, p. 565, doi. 10.1002/cpt.246
- Article
34
- Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 6, p. 581, doi. 10.1002/cpt.518
- Article
35
- Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 5, p. 406, doi. 10.1002/cpt.451
- Article
36
- Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 4, p. 305, doi. 10.1002/cpt.240
- Article
37
- Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 4, p. 317, doi. 10.1002/cpt.431
- Article
38
- Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 206, doi. 10.1002/cpt.410
- Article
39
- Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 2, p. 121, doi. 10.1002/cpt.398
- Article
40
- Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 1, p. 2, doi. 10.1002/cpt.233
- Article
41
- Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 1, p. 14, doi. 10.1002/cpt.387
- Article
42
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 6, p. 577, doi. 10.1002/cpt.370
- Article
43
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 5, p. 473, doi. 10.1002/cpt.356
- Article
44
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 4, p. 345, doi. 10.1002/cpt.342
- Article
45
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 3, p. 257, doi. 10.1002/cpt.325
- Article
46
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 2, p. 132, doi. 10.1002/cpt.306
- Article
47
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 1, p. 18
- Article
48
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 1, p. 18
- Article
49
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 1, p. 17
- Article
50
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 1, p. 17
- Article